Descriptive sheet

LICOSER

Food supplement based on Serenoa repens, lycopene, zinc, vitamin E, useful for filling deficiencies in case of increased needs or reduced dietary intake. It can be used as an adjuvant in maintaining the physiological properties of the prostate gland.
Serenoa Repens (synonym of Sabal Serrulata)
Plant widespread in the United States, Southern Europe and North Africa. The most important chemical constituents are different sterols, free fatty acids, carotenoids, essential oils and polysaccharides.
Useful for the proper functioning of the urinary tract and prostate.
Lycopene
Natural pigment belonging to the carotenoid class, it is characterized by antioxidant properties similar to those of beta-carotene, but is much more powerful, therefore much more effective in preventing damage from oxygen free radicals. In nature, Lycopene is present in tomatoes and other plant substances; endowed with high antioxidant activity, it is considered among the carotenoids the most powerful "scavenger" (scavenger) of oxygen free radicals.
Urtica Dioica
Perennial herbaceous plant, native to Western Asia, widespread in all temperate regions, including Italy. In modern phytotherapy the root plays a leading role, in fact it is rich in phytosterols (α-sitosterol, daucosterol and related glucosides), with a mechanism of action similar to those of Serenoa but also contains lecithins (scopoletin) that inhibit EGF (Epidermal Grow Factor) a cellular growth factor capable of reducing symptoms and partially also the volume of the gland. Therefore the root extract of Urtica Dioica is particularly beneficial for limiting the growth of prostatic tissue induced by androgens and in particular by dihydrotestosterone.
Green tea
It is obtained from the leaf buds and young leaves of the plant known by the scientific name of "Camelia sinensis". The peculiarity of this plant is given by the high antioxidant potential.
It contains neither gluten nor sugars.

Ingredients

	for 1 tablet (1200 mg)
Serenoa repens (es 30% Total fatty acids)	320 mg
Lycopene	8 mg
Zinc	11.25 mg
Vitamin E	15 mg

How to use
The treatment involves taking 1 - 2 tablets per day for a period of at least 6 - 12 months.
It can be taken at any time of the day and during meals or away from meals.

Warnings
Do not exceed the recommended daily dose. Keep out of reach of children under 3 years of age. Supplements should not be considered as a substitute for a varied diet. Pregnant or breastfeeding women and children are advised to seek medical advice.

Format
Pack of 30 tablets.

Cod. 1010007.

Bibliography
- Carilla E,Briley M,Fauran F,Sultan C,Duvilliers C. Binding of Permixon, a new treatment for prostatic benign hyperplasia, to the cytosolic androgen receptor in the rat prostate.J Steroid Biochem 1984;20:521-3.
- Champault G, Patel JC, Bonnard QAM. A double-blind trial of an extract of the plant Serenoa repens in benign prostatic hyperplasia.Br J Clin Pharmacol 1984;18:461-2.
- De Bruyne F. et al. Evaluation of the clinical benefit Serenoa Repens and Tamsulosin in severe BPH patients-Personal study subset analysis.Eur.Urol. 2004 Jun;45(6):773-9;Discussion 779-80,2004.
- Boyle P, Robertson C, Lowe F, Roehrborn C. Meta-analysis of clinical trials of Permixon in the treatment of symptomatic benign prostatic hyperplasia. Urology 2000;55:533-9.
- Bent S. et al. Saw Palmetto for benign prostatic hyperplasia. N.Engl.J. Med. 354(6):557-66,2006.
- Wilt T,Ishani A,Stark G,Mac donald R,Mulrow C,Lau J.Serenoa repens for benign prostatic hyperplasia.Cochrane Database Syst Rev 2000;2:CD001423.
- Fong YK, Milani S, Djavan B, Role of phytotherapy in men with lower urinary tract symptoms. Curr opinion urol.2005; 15(1); 45-48.
- Wilt T, Ishani A, Mac Donald R, Serenoa repens for benign prostatic hyperplasia. Cochrane Database Syst Rev,2002; 3; CDCD001423.
- Strauch G, Perles P, Vergult G, et al. Comparison of finasteride and Serenoa repens in the inhibition of 5-alpha reductase in healthy male volunteers. Eur.Urology 1994; 26:3, 247-252.
- Debruyne F, Boyle P, Calais da Silva F, Gillenwater JG, Hamdy FC, Perrin P, Teillac P, Vela-Navarrete R, Raynaud JP, Schulman C, Evaluation of the clinical benefit of permixon and tamsulosin in severe BPH patients- PERMAL study subset analysis. Prog Urol, 2004 Jun;14(3):326-331.
- Avins AL et al. A detailed safety assessment of a Saw Palmetto extract.Complement ther med. 16(3):147-154,2008.
- Levy J.,Bosin E. Et al.,Lycopene is a more potent inhibitor of human cancer cell proliferation than either a-carotene or b-carotene.Nutr. Cancer,1995;24: 257-266.
- Sökeland J. Combined sabal and urtica extract compared with finasteride in men with benign prostatic hyperplasia: analysis of prostate volume and therapeutic outcome. BJU ext 200; 86(4):439-442.
- Schneider T, Rubben H, Stinging nettle root extract in long-term treatment of benign prostatic syndrome (BPS). Results of a randomized, double-blind, placebo controlled multicenter study after 12 months. Urologe A, 2004; 43(3): 302-306.
- Lichius JJ, The inhibiting effects of components of stinging nettle roots on experimentally induced prostatic hyperplasia in mice. Planta Med,1999;65, 7: 666-668.
- Bombardelli E, Morazzoni P, Urtica Dioica L. Phytotherapy 1997; 68,5, 387-402.
- Chem Pharm, Bulletin 38-1990.
- Kurahashi N, Inoue M, Iwasaki M, Sasazuki S, Tsugane AS, Japan Public Health Center-Based Prospective Study Group. Dairy product, saturated fatty acid, and calcium intake and prostate cancer in a prospective cohort of Japanese men. Cancer Epidemiol Biomarkers Prev, 2008 Apr; 17 (4): 930-937.
- Betuzzi S, Brausi M, Rizzi F, Castagnetti G, Peracchia G, Corti A, Chemoprevention of human prostate cancer by oral administration of green tea catechins in volunteers with high-grade prostate intraepithelial neoplasia: a preliminary report from a one-year proof -of-principle study. cancer Res,2006 Jan 15;66(2): 1234-1240.
- Etminan M, Takkouche B, Caamano-Isorna F The role of tomato products and lycopene in the prevention of prostate cancer: a meta-analysis of observational studies. Cancer Epidemiol Biomarkers Prev, 2004 Mar; 13 (3): 340-345.
- Michael B. Sporn and Karen T. Liby Is Lycopene an effective Agent for preventing prostate cancer? Cancer Prevention Research 03-14-2013.